BPG is committed to discovery and dissemination of knowledge
Systematic Reviews
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Methodol. Jun 20, 2026; 16(2): 111025
Published online Jun 20, 2026. doi: 10.5662/wjm.v16.i2.111025
Clinical insights into levothyroxine overdose: A systematic review
Fateen Ata, Haseeb Ahmad Khan, Aamna Kashif, Adeel Ahmad Khan, Rabia Fawad, Hafiz Waqas Younas, Bilal Ahmed, Huzaifa Javed
Fateen Ata, Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH 44118, United States
Haseeb Ahmad Khan, Internal Medicine, The Rotherham NHS Foundation Trust, Yorkshire S60 2UD, United Kingdom
Aamna Kashif, Medicine, Faisalabad Medical University, Faisalabad 38000, Punjab, Pakistan
Adeel Ahmad Khan, Internal Medicine, Cleveland Clinic Akron General Hospital, Akron, OH 44301, United States
Rabia Fawad, Medicine, Niazi Medical and Dental college, Sargodha 40100, Punjab, Pakistan
Hafiz Waqas Younas, Emergency Medicine, NHS Stockport Foundation Trust, Manchester SK2 7JE, United Kingdom
Bilal Ahmed, Endocrinology, University Hospital of Coventry and Warwickshire, West Midlands CV2 2DX, United Kingdom
Huzaifa Javed, Internal Medicine, Griffin Health, Derby, CT 06418, United States
Co-first authors: Fateen Ata and Haseeb Ahmad Khan.
Author contributions: Ata F designed the research, supervised the project; Ata F, Khan HA, Kashif A, Khan AA, Fawad R, Younas HW, Ahmed B, Javed H did the literature review; Ata F, Khan HA, Younas HW screened articles; Khan HA, Younas HW, Javed H, Fawad R, and Ahmed B collected data; Ata F and Khan AA analyzed the data; Ata F, Khan HA, and Kashif A wrote the paper.
Conflict-of-interest statement: There is no conflict of interest to disclose.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Corresponding author: Fateen Ata, MD, Internal Medicine, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44118, United States. docfateenata@gmail.com
Received: June 23, 2025
Revised: August 9, 2025
Accepted: November 11, 2025
Published online: June 20, 2026
Processing time: 306 Days and 20.6 Hours
Abstract
BACKGROUND

Levothyroxine (LTX) is one of the most commonly used medications due to the high prevalence of hypothyroidism in various age groups. Overdose (OD) with LTX, intentional or unintentional, is rare but can have clinically significant and even life-threatening consequences. Data on clinical outcomes of patients with LTX OD are limited, and guidelines on its management are suboptimal.

AIM

To compile all available data on the clinical characteristics, management, and outcomes of patients with LTX OD.

METHODS

A systematic literature search was conducted to identify English-language articles through PubMed, Scopus, and EMBASE that reported primary patient data on LTX OD in all age groups. All analyses were performed using STATA-18.

RESULTS

Forty-nine studies, comprising 95 individual cases and six larger retrospective studies (n = 11513), were analyzed. The median age of patients in case reports was 20 years (3.5-42), with a female preponderance (66.1%). The median ingested dose of LTX was 4250 μg (1250-10000), with a median time to presentation of 4.5 hours (1.5–24). Tachycardia (38.9%), confusion (23.2%), and fever (18.9%) were the most frequent symptoms. Severe complications included atrial fibrillation (5.3%), and one death was reported. Patients with intentional LTX OD were significantly older (median 35.5 vs 3.5 years, P < 0.001) and had higher diastolic blood pressure (P = 0.003), while non-intentional OD cases had higher heart rates (P = 0.02). Among the 11513 patients from larger studies, more than 90% experienced minimal or no symptoms, particularly in pediatric cohorts. Rarely severe outcomes, such as coma and cardiac failure, were observed in adults with high-dose ingestions, requiring interventions such as beta-blockers, corticosteroids, and plasmapheresis.

CONCLUSION

This study provides the first comprehensive dataset on LTX OD. Patients with non-suicidal/accidental LTX OD mainly belong to the pediatric age group, while those with suicidal intent belong to the older age group. Despite the risk of toxicity with ingestion of high doses of LTX, mortality is extremely rare.

Keywords: Levothyroxine; Overdose; Toxicity; Thyroid; Suicide; Thyroxine

Core Tip: This systematic review presents the most comprehensive data synthesis on levothyroxine (LTX) overdose (OD) across all age groups. It highlights key clinical patterns that distinguish unintentional pediatric OD from intentional adult OD, with the latter exhibiting more prominent symptom severity. Despite wide dose variability, mortality was rare. Most cases were managed conservatively. Extracorporeal modalities were employed in cases that were severe and refractory. This systematic review highlights the need for treatment protocols and prevention strategies for LTX toxicity, providing valuable insights for clinicians managing thyroid hormone toxicity.